In addition, considering the potential application value of GLP-2 analogues in metabolic diseases such as obesity and diabetes, in-depth exploration of their role in energy metabolism will have significant translational medical significance. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.